Literature DB >> 6370416

Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma.

S Matsubayashi, C Yanaihara, M Ohkubo, S Fukata, Y Hayashi, H Tamai, T Nakagawa, A Miyauchi, K Kuma, K Abe.   

Abstract

Two cases of gastrin releasing peptide (GRP)-producing medullary thyroid carcinoma are presented. Immunohistochemical examination revealed the presence of GRP-like immunoreactivity (IR-GRP) in the primary tumor tissues. High concentration of IR-GRP was also demonstrated in extracts of the primary tumors by radioimmunologic means with use of a GRP-specific antiserum. Chromatographic analysis showed that the immunoreactivity was composed of at least two molecular forms: one behaved as synthetic porcine GRP on Sephadex G-50 gel filtration and the other as porcine GRP (14-27), a C-terminal active fragment of GRP. The IR-GRP was shown not to be attributed to bombesin-like immunoreactivity. Substance P-like immunoreactivity was not detected in the tumor tissues by either immunohistochemical or radioimmunologic means. This is, as far as the authors are aware, the first finding of IR-GRP as an ectopic product in medullary carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370416     DOI: 10.1002/1097-0142(19840601)53:11<2472::aid-cncr2820531118>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancer.

Authors:  A J Vangsted; E V Andersen; L Nedergaard; J Zeuthen
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

2.  Ultrastructural demonstration of calcitonin in osmium-fixed human medullary carcinoma of thyroid by the protein A-colloidal gold technique.

Authors:  T Suzuki; S Ito; Y Yamada; F Matsuzuka; S Matsubayashi; A Miyauchi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture.

Authors:  E Jimenez-Hakim; M el-Azouzi; P M Black
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

4.  Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors.

Authors:  Y Qin; G Halmos; R Z Cai; B Szoke; T Ertl; A V Schally
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells.

Authors:  I Zachary; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Receptor for bombesin with associated tyrosine kinase activity.

Authors:  D M Cirillo; G Gaudino; L Naldini; P M Comoglio
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding.

Authors:  I Zachary; J W Sinnett-Smith; E Rozengurt
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.